Lu Yue
Zhejiang Ocean University(CN)Tengzhou Central People's Hospital(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related molecular mechanisms research, RNA modifications and cancer, Peptidase Inhibition and Analysis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Prognostic value of CRM1in pancreas cancer(2009)149 cited
- Prognostic value of CRM1 in pancreas cancer.(2009)
- → MiR‐200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1(2015)70 cited
- → P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer(2017)68 cited
- → Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study(2021)65 cited
- → CRM1 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas(2013)59 cited
- → miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression(2015)50 cited
- → Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy(2022)48 cited
- → Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis(2016)42 cited
- → Thrombospondin-1 expression in oral squamous cell carcinomas: correlations with tumor vascularity, clinicopathological features and survival(2000)41 cited